SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANMR and MAMO Ready to EXPLODE!! Nat'l Health Priority...
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Graham Dellaire who wrote (4)2/10/1997 9:50:00 PM
From: bottomfish   of 53
 
ANOTHER CONCERN FOR ANMR. Maybe Warren may have some input. Many companies who are cash poor sale more stock thus deluting the price per share. Their breast imaging MRI program is still in progam and development phase. These imaging centers are expensive. What is going to make this a blue chip company is that they will have mass produce MRI imaging machines and this is going to take a lot of capital. Thus you may see a total buy out of ANMR/MAMO by a large medical techinical corporation, or they will sell licenses. In any case it seems what I am reading about ANMR/MAMO, is that they are in a strong position to deal. Warren, reported 22 patents under ANMR control.

This stock is for long term investments not for a trader. On the other hand, if FDA came out with major release on the technology or ANMR products, again it could reach its historical levels of $5.00 to
8.00 per share.

Waren, what do you think? Especially about the direction they are going by selling one of their imaging centers.

Bart
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News